Table 1 Summary of studies reporting skin disorders prevalence in DM 1 and DM 2 patients, with a subjects description (number of subjects in the study, type of DM evaluated, country/region where the study was conducted, subjects mean age), prevalence of skin condition and the most common skin condition in each study
From: Skin disorders in diabetes mellitus: an epidemiology and physiopathology review
Author | Sample size | DM type | Country/region | Age (years) | Overall prevalence (%) | Overall most frequent skin disorder among all disorders (%) |
|---|---|---|---|---|---|---|
Sasmaz et al. [5] | 151 | Type 2 | India | 54 ± 17 | 85.4 | Cutaneous infection (20.6 %) |
Chatterjee, et al. [13] | 680 | Types 1 and 2 | India | 46.3 ± 6.7 | 73.9 | Cutaneous infection (40.9 %) |
Farshchian et al. [9] | 155 | Types 1 and 2 | Iran | 21.8 ± 4.9 and 57.2 ± 9.7, type 1 and 2, respectively | 71 | Cutaneous infection |
Foss et al. [6] | 403 | Types 1 and 2 | Brazil | 19.9 ± 2.3 and 63.1 ± 3.4 type 1 and 2, respectively | 81 | Cutaneous infection (82.6 %) |
Wambier et al. [10] | 500 | Types 1 and 2 | Brazil | 45.5 ± 20 | 97 | Cutaneous infection (i.e.Tinea pedis) (35 %) |
da Silva et al. [11] | 55 | Type 2 | Brazil | 56.3 ± 13.4 | 89.1 | Yellow nails (52.7 %) and candidiasis (52.7 %) |
Galdeano et al. [12] | 125 | Types 1 and 2 | Argentina | 58.9 ± 15.43 | 90.4 | Xeroderma (69 %) |
Pavlovic et al. [14] | 212 | Type 1 | Servia | 12.5 ± 3.7 | 68 | Xerosis (22.2 %) |
Romano et al. [4] | 457 | Types 1 and 2 | Italy | 61.5 ± 11.3 | 60 | Cutaneous infection |
Sanad et al. [7] | 100 | Types 1 and 2 | Egypt | 51.42 ± 14.66 | – | Cutaneous infection (40 %) |
Sawatkar et a [15]l | 500 | Type 1 | South Asia | 16.9 ± 6.9 | 67.8 | Limited joint mobility (16.8 %) |
Goyal et al. [8] | 100 | Types 1 and 2 | India | 57.44 ± 10.37 | – | Xerosis (44 %) |
Ragunatha et al. [17] | 500 | Types 1 and 2 | India | 55.24 ± 11.24 | 51.1 | Cutaneous infection |